» Articles » PMID: 22547698

Delays and Diversions Mark the Development of B Cell Responses to Borrelia Burgdorferi Infection

Overview
Journal J Immunol
Date 2012 May 2
PMID 22547698
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

B cell responses modulate disease during infection with Borrelia burgdorferi, the causative agent of Lyme disease, but are unable to clear the infection. Previous studies have demonstrated that B. burgdorferi infection induces predominantly T-independent B cell responses, potentially explaining some of these findings. However, others have shown effects of T cells on the isotype profile and the magnitude of the B. burgdorferi-specific Abs. This study aimed to further investigate the humoral response to B. burgdorferi and its degree of T cell dependence, with the ultimate goal of elucidating the mechanisms underlying the failure of effective immunity to this emerging infectious disease agent. Our study identifies distinct stages in the B cell response using a mouse model, all marked by the generation of unusually strong and persistent T-dependent and T-independent IgM Abs. The initial phase is dominated by a strong T-independent accumulation of B cells in lymph nodes and the induction of specific Abs in the absence of germinal centers. A second phase begins around week 2.5 to 3, in which relatively short-lived germinal centers develop in lymph nodes, despite a lymph node architecture that lacks clearly demarcated T and B cell zones. This response failed, however, to generate appreciable numbers of long-lived bone marrow plasma cells. Finally, there is a slow accumulation of long-lived Ab-secreting plasma cells in bone marrow, reflected by a strong but ultimately ineffective serum Ab response. Overall, the study indicates that B. burgdorferi might evade B cell immunity by interfering with its response kinetics and quality.

Citing Articles

Bridging the gap: Insights in the immunopathology of Lyme borreliosis.

Snik M, Stouthamer N, Hovius J, van Gool M Eur J Immunol. 2024; 54(12):e2451063.

PMID: 39396370 PMC: 11628917. DOI: 10.1002/eji.202451063.


Hitchhiker's Guide to .

Bourgeois J, Hu L J Bacteriol. 2024; 206(9):e0011624.

PMID: 39140751 PMC: 11411949. DOI: 10.1128/jb.00116-24.


IL-12 induces a B cell-intrinsic IL-12/IFNγ feed-forward loop promoting extrafollicular B cell responses.

Elsner R, Smita S, Shlomchik M Nat Immunol. 2024; 25(7):1283-1295.

PMID: 38862796 DOI: 10.1038/s41590-024-01858-1.


Suppression of host humoral immunity by varies over the course of infection.

Williams M, Zhang Y, Pulse M, Berg R, Allen M Infect Immun. 2024; 92(4):e0001824.

PMID: 38514468 PMC: 11003232. DOI: 10.1128/iai.00018-24.


Host glycosylation of immunoglobulins impairs the immune response to acute Lyme disease.

Haslund-Gourley B, Hou J, Woloszczuk K, Horn E, Dempsey G, Haddad E EBioMedicine. 2024; 100:104979.

PMID: 38266555 PMC: 10818078. DOI: 10.1016/j.ebiom.2024.104979.


References
1.
Tunev S, Hastey C, Hodzic E, Feng S, Barthold S, Baumgarth N . Lymphoadenopathy during lyme borreliosis is caused by spirochete migration-induced specific B cell activation. PLoS Pathog. 2011; 7(5):e1002066. PMC: 3102705. DOI: 10.1371/journal.ppat.1002066. View

2.
Bacon R, Kugeler K, Mead P . Surveillance for Lyme disease--United States, 1992-2006. MMWR Surveill Summ. 2008; 57(10):1-9. View

3.
Steere A . Lyme disease. N Engl J Med. 2001; 345(2):115-25. DOI: 10.1056/NEJM200107123450207. View

4.
Barthold S, Sidman C, Smith A . Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am J Trop Med Hyg. 1992; 47(5):605-13. DOI: 10.4269/ajtmh.1992.47.605. View

5.
Diamond M, Shrestha B, Mehlhop E, Sitati E, Engle M . Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol. 2003; 16(3):259-78. DOI: 10.1089/088282403322396082. View